Skip to content

Comparing the clacitonin transforaminal epidural injection with caudal epidural injection in degenerative spinal canalstenosis

Evaluation the effects of clacitonin transforaminal epidural injection with caudal epidural injection in patients with degenerative spinal canalstenosis; a double-blinded randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120814010599N29
Enrollment
40
Registered
2021-04-21
Start date
2021-04-30
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group 1: In the calcitonin epidural caudal group, calcitonin will be injected with a dose of 50 IU (Caspiantamin company). Intervention 2: Intervention group 2: In the cl

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Chronic low back pain with a history of more than six months with or without dissemination to the lower extremity Moderate to high pain (pain score over 3) Age between 40 to 70 years Lack of proper response to drug treatments and conservative for three months Absence of protruding disc Severe channel tightness Lack of reduction in vertebral height be more than 60%

Exclusion criteria

Exclusion criteria: Severe spinal deformity Spinal tumors Spinal fracture Local or systemic infection Anticoagulant drug use History of severe mental illness Pregnancy and lactation Patient dissatisfaction

Design outcomes

Secondary

MeasureTime frame
Inability to stand due to pain. Timepoint: Four times including two weeks later, 1 month, 3 months and 6 months after surgery. Method of measurement: Oswestry Low Back Pain Disability questionnaire.

Primary

MeasureTime frame
Pain. Timepoint: Four times including two weeks later, 1 month, 3 months and 6 months after surgery. Method of measurement: Visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPoupak Rahimzadeh

Iran University of Medical Sciences

p-rahimzadeh@tums.ac.ir+98 21 6650 9059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026